Cellular retinoic acid bioavailability determines epithelial integrity: Role of retinoic acid receptor α agonists in colitis

Molecular Pharmacology

Volumn 71, Issue 1, 2007, Pages 250-258

  Osanai, Makoto ^a   Nishikiori, Nami ^a   Murata, Masaki ^a   Chiba, Hideki ^a   Kojima, Takashi ^a   Sawada, Norimasa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CLAUDIN 1; CLAUDIN 4; CYTOCHROME P450; INSULIN; MANNITOL; OCCLUDIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR ALPHA AFFECTING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE PERMEABILITY; COLITIS; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG MECHANISM; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TIGHT JUNCTION;

ANIMALS; BACTERIAL TRANSLOCATION; BIOLOGICAL AVAILABILITY; CELL LINE; CELL MEMBRANE; COLITIS; CYTOCHROME P-450 ENZYME SYSTEM; DOGS; HUMANS; KIDNEY; RECEPTORS, RETINOIC ACID; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TRETINOIN; UROTHELIUM;

EID: 33845876617     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.029579     Document Type: Article

References (35)

1. Abu-Abed S, Dolle P, Metzger D, Beckett B, Chambon P, and Petkovich M (2001) The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev 15:226-240.
2. Asfaha S, MacNaughton WK, Appleyard CB, Chadee K, and Wallace JL (2001) Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation. Am J Physiol 281:G635-G644.
3. Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, et al. (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 6:583-588.
4. Cantorna MT, Nashold FE, and Hayes CE (1994) In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol 152:1515-1521.
5. Clayburgh DR, Shen L, and Turner JR (2004) A porous defense: the leaky epithelial barrier in intestinal disease. Lab Investig 84:282-291.
6. de Thé H (1996) Altered retinoic acid receptors. FASEB J 10:955-960.
7. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, and Van Rees EP (1998) Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114:385-391.
8. Durston AJ, Timmermans JP, Hage WJ, Hendriks HF, de Vries NJ, Heideveld M, and Nieuwkoop PD (1989) Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature (Lond) 340:140-144.
9. Fasano A and Shea-Donohue T (2005) Mechanisms of disease: The role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2:416-422.
10. Furuse M, Furuse K, Sasaki H, and Tsukita S (2001) Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153:263-272.
11. Gordon JN, Sabatino AD, and MacDonald TT (2005) The pathophysiologic rationale for biological therapies in inflammatory bowel disease. Curr Opin Gastroenterol 21:431-437.
12. Grencis RK and Bancroft AJ (2004) Interleukin-13: a key mediator in resistance to gastrointestinal-dwelling nematode parasites. Clin Rev Allergy Immunol 26:51-60.
13. Howe KL, Reardon C, Wang A, Nazli A, and McKay DM (2005) Transforming growth factor-β regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am J Pathol 167:1587-1597.
14. Ishizaki T, Chiba H, Kojima T, Fujibe M, Soma T, Miyajima H, Nagasawa K, Wada I, and Sawada N (2003) Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp Cell Res 290:275-288.
15. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, and Haase VH (2004) Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Investig 114:1098-1106.
16. Kastner P, Mark M, and Chambon P (1995) Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell 83:859-869.
17. Kubota H, Chiba H, Takakuwa Y, Osanai M, Tobioka H, Kohama G, Mori M, and Sawada N (2001) Retinoid X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endoderm differentiation. Exp Cell Res 263:163-172.
18. Luu L, Ramshaw H, Tahayato A, Stuart A, Jones G, White J, and Petkovich M (2001) Regulation of retinoic acid metabolism. Adv Enzyme Regul 41:159-175.
19. Mankertz J, Tavalali S, Schmitz H, Mankertz A, Riecken EO, Fromm M, and Schulzke JD (2000) Expression from the human occludin promoter is affected by tumor necrosis factor α and interferon γ. J Cell Sci 113:2085-2090.
20. Matter K, Aijaz S, Tsapara A, and Balda MS (2005) Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 17:1-6.
21. McCullough FS, Northrop-Clewes CA, and Thurnham DI (1999) The effect of vitamin A on epithelial integrity. Proc Nutr Soc 58:289-293.
22. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, and Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795-803.
23. Osanai M, Murata M, Nishikiori N, Chiba H, Kojima T, and Sawada N (2006) Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res 66:9125-9133.
24. Osanai M and Petkovich M (2005) Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. Mol Pharmacol 67:1808-1817.
25. Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT, and Collins JE (2005) Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Investig 85:1139-1162.
26. Prosser C, Stelwagen K, Cummins R, Guerin P, Gill N, and Milne C (2004) Reduction in heat-induced gastrointestinal hyperpermeability in rats by bovine colostrum and goat milk powders. J Appl Physiol 96:650-654.
27. Rogler G (2006) Significance of anti-inflammatory effects of PPARgamma agonists? Gut 55:1067-1069.
28. Sommer A, Tarwotjo I, Djunaedi E, West KP Jr, Loeden AA, Tilden R, and Mele L (1986) Impact of vitamin A supplementation on childhood mortality: a randomized controlled community trial. Lancet 1:1169-1173.
29. Strober W. Fuss IJ, Nakamura K, and Kitani A (2003) Recent advances in the understanding of the induction and regulation of mucosal inflammation. J Gastroenterol 38:55-58.
30. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, and Wu GD (1999) A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Investig 104:383-389.
31. Taimi M, Helvig C, Wisniewski J, Ramshaw H, White J, Amad M, Korczak B, and Petkovich M (2004) A novel cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J Biol Chem 279:77-85.
32. Tobioka H, Isomura H, Kokai Y, Tokunaga Y, Yamaguchi J, and Sawada N (2004) Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol 35:159-164.
33. Tsukita S, Furuse M, and Itoh M (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2:285-293.
34. Van Leeuwen PA, Boermeester MA, Houdijk AP, Ferwerda CC, Cuesta MA, Meyer S, and Wesdorp RI (1994) Clinical significance of translocation. Gut 35 (1 Suppl): S28-S34.
35. White JA, Beckett-Jones B, Guo YD, Dilworth FJ, Bonasoro J, Jones G, and Petkovich M (1997) cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J Biol Chem 272:18538-18541.